RT Journal Article
T1 Pharmacotherapy of traumatic childhood aphasia: beneficial effects of donepezil alone and combined with intensive naming therapy
A1 Dávila, Guadalupe
A1 Moyano, María Pilar
A1 Edelkraut, Lisa
A1 Moreno-Campos, Lorena
A1 Berthier, Marcelo L
A1 Torres-Prioris, María José
A1 López-Barroso, Diana
K1 Quimioterapia
K1 Afasia
K1 Niños -- Enfermedades
AB Currently, language therapy is the only treatment for childhood aphasia (CA). This study explored using the cognitive-enhancing drug donepezil (DP) to improve language recovery in a 9-year-old girl with chronic anomic aphasia caused by left temporal-parietal brain injury. The study involved DP treatment alone, combined with intensive naming therapy (INT), and washout periods. Results showed that DP alone improved spontaneous speech, comprehension, repetition, and attention, while combining DP with INT further enhanced naming abilities. Improvements remained after treatment, and DP had no side effects, enabling the child to return to regular schooling. Further research is needed to confirm these findings.
PB Frontiers Media
YR 2020
FD 2020-07-31
LK https://hdl.handle.net/10630/34323
UL https://hdl.handle.net/10630/34323
LA eng
NO Dávila, G., Moyano, M. P., Edelkraut, L., Moreno-Campos, L., Berthier, M. L., Torres-Prioris, M. J., & López-Barroso, D. (2020). Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy. Frontiers in pharmacology, 11, 1144. https://doi.org/10.3389/fphar.2020.01144
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 20 ene 2026